Hereditary elliptocytosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:288OMIM:617948D58.1
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary elliptocytosis (HE), also known as hereditary ovalocytosis, is a group of inherited red blood cell membrane disorders characterized by the presence of elliptical (oval-shaped) erythrocytes on peripheral blood smear. The condition results from defects in proteins that form the red blood cell cytoskeleton, most commonly alpha-spectrin (SPTA1), beta-spectrin (SPTB), protein 4.1 (EPB41), or glycophorin C (GYPC). These structural protein abnormalities weaken the mechanical stability of the red blood cell membrane, causing the normally biconcave disc-shaped cells to become elongated and elliptical, particularly when subjected to shear stress in the circulation. The clinical spectrum of hereditary elliptocytosis is highly variable. The majority of affected individuals (approximately 90%) are asymptomatic carriers who are identified incidentally through a routine blood smear showing elliptocytes. However, a subset of patients may experience mild to moderate chronic hemolytic anemia with symptoms including fatigue, jaundice, splenomegaly, and gallstones. In rare cases, particularly in homozygous or compound heterozygous states, severe hemolytic anemia can occur, sometimes presenting in the neonatal period with significant jaundice and anemia requiring transfusion. A related severe variant, hereditary pyropoikilocytosis (HPP), is characterized by marked red cell fragmentation and severe hemolysis, often presenting in infancy. Treatment of hereditary elliptocytosis depends on clinical severity. Most patients require no treatment. For those with clinically significant hemolysis, folic acid supplementation is recommended to support increased red blood cell production. Splenectomy may be considered in patients with moderate to severe hemolytic anemia, as it can reduce the rate of red cell destruction and improve anemia, though it does not correct the underlying membrane defect. Neonatal cases may require phototherapy or exchange transfusion for hyperbilirubinemia. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal erythrocyte morphologyHP:0001877ElliptocytosisHP:0004445Increased red cell osmotic fragilityHP:0005502Neonatal hyperbilirubinemiaHP:0003265StomatocytosisHP:0004446PoikilocytosisHP:0004447Congenital hemolytic anemiaHP:0004804
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary elliptocytosis.

View clinical trials →

No actively recruiting trials found for Hereditary elliptocytosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary elliptocytosis community →

Specialists

3 foundView all specialists →
JM
Josef T Prchal, MD
SALT LAKE CITY, UT
Specialist
PI on 5 active trials
MP
María del Mar Mañú Pereira, PhD
Specialist
PI on 1 active trial
PM
Pablo Velasco Puyó, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary elliptocytosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary elliptocytosisForum →

No community posts yet. Be the first to share your experience with Hereditary elliptocytosis.

Start the conversation →

Latest news about Hereditary elliptocytosis

No recent news articles for Hereditary elliptocytosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary elliptocytosis

What is Hereditary elliptocytosis?

Hereditary elliptocytosis (HE), also known as hereditary ovalocytosis, is a group of inherited red blood cell membrane disorders characterized by the presence of elliptical (oval-shaped) erythrocytes on peripheral blood smear. The condition results from defects in proteins that form the red blood cell cytoskeleton, most commonly alpha-spectrin (SPTA1), beta-spectrin (SPTB), protein 4.1 (EPB41), or glycophorin C (GYPC). These structural protein abnormalities weaken the mechanical stability of the red blood cell membrane, causing the normally biconcave disc-shaped cells to become elongated and e

How is Hereditary elliptocytosis inherited?

Hereditary elliptocytosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Hereditary elliptocytosis?

3 specialists and care centers treating Hereditary elliptocytosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.